摘要
近年来,2型糖尿病患病率急剧上升,而2型糖尿病患者以肥胖者居多。若BMI≥28 kg/m2同时符合2型糖尿病的诊断标准,称为肥胖型2型糖尿病。对于肥胖型2型糖尿病患者,肥胖和2型糖尿病1+1>2的叠加效应致使该类患者心脑血管疾病甚至死亡的发生风险较常人明显上升。黄连降糖片治疗肥胖型2型糖尿病疗效显著,在以往的临床研究及动物实验中证实了其具有调节糖脂代谢,改善胰岛素抵抗的作用,与西医降糖药相比,在控制血糖方面作用接近,而在缓解症状、减重、改善胰岛功能等方面具有明显优势。
In recent years,the prevalence of type 2 diabetes has risen sharply,and the majority of people with type 2 diabetes are obese. If BMI≥28 kg/m^2 and met the diagnostic criteria of type 2 diabetes,known as obese type 2 diabetes. For obese patients with type 2 diabetes,obesity and type 2 diabetes one plus one is greater than two of the superimposed effect of causing this kind of patients with cardiovascular and cerebrovascular diseases and even death risk than average increased significantly. Therefore,the prevention and treatment of obesity type 2 diabetes is urgent. Huanglian Jiangtang tablet is effective in the treatment of obese type 2 diabetes mellitus. It has been proved to be effective in regulating glucose and lipid metabolism and improving insulin resistance in previous clinical studies and animal experiments,compared with western hypoglycemic drugs. It has the same effect in controlling blood sugar,but it has obvious advantages in relieving symptoms,losing weight and improving the function.
作者
闫爱华
张瑞帅
闫镛
YAN Aihua;ZHANG Ruishuai;YAN Yong(The Second School of Clinical Medicine,Henan University of Traditional Chinese Medicine,Henan Province,Zhengzhou 450000,China;Department of Endocrinology,Kaifeng Hospital of Traditional Chinese Medicine,Henan Province,Kaifeng 475000,China)
出处
《光明中医》
2018年第13期1955-1957,共3页
GUANGMING JOURNAL OF CHINESE MEDICINE
基金
河南省中医药科学研究专项课题(No.20152Y02002)
关键词
肥胖
2型糖尿病
黄连降糖片
BMI
减重
Obese
Type 2 diabetes mellitus
Huanglian Jiangtang tablets
BMI
Weight loss